Fernando Aguirre Synchrony Financial (SYF) insider trading activity

Fernando Aguirre is Director of Synchrony Financial. Currently has a direct ownership of 24,568 shares of SYF, which is worth approximately $1.62 Million. The most recent transaction as insider was on Nov 15, 2024, when has been sold 15 shares (Dividend Equivalent Unit) at a price of $64.98 per share, resulting in proceeds of $974. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.6K

3.55% 3M change

18.51% 12M change

Total Value Held $1.62 Million

FERNANDO AGUIRRE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2024	BUY Grant, award, or other acquisition	$974 $64.98 p/Share	15 Added 0.06%	24,568 Dividend Equivalent Unit
Sep 30 2024	BUY Grant, award, or other acquisition	$41,250 $49.88 p/Share	827 Added 3.26%	24,553 Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	$1,055 $45.89 p/Share	23 Added 0.1%	23,726 Dividend Equivalent Unit
Jun 30 2024	BUY Grant, award, or other acquisition	$41,291 $47.19 p/Share	875 Added 3.56%	23,703 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	$1,147 $44.14 p/Share	26 Added 0.11%	22,828 Dividend Equivalent Unit
Mar 31 2024	BUY Grant, award, or other acquisition	$41,265 $43.12 p/Share	957 Added 4.03%	22,802 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	$1,315 $39.85 p/Share	33 Added 0.15%	21,845 Dividend Equivalent Unit
Dec 31 2023	BUY Grant, award, or other acquisition	$41,283 $38.19 p/Share	1,081 Added 4.72%	21,812 Common Stock
Nov 09 2023	BUY Grant, award, or other acquisition	$1,311 $29.15 p/Share	45 Added 0.22%	20,731 Dividend Equivalent Unit
Sep 30 2023	BUY Grant, award, or other acquisition	$41,269 $30.57 p/Share	1,350 Added 6.13%	20,686 Common Stock
Aug 10 2023	BUY Grant, award, or other acquisition	$1,341 $34.4 p/Share	39 Added 0.2%	19,336 Dividend Equivalent Unit
Jun 30 2023	BUY Grant, award, or other acquisition	$41,280 $33.92 p/Share	1,217 Added 5.93%	19,297 Common Stock
May 12 2023	BUY Grant, award, or other acquisition	$1,299 $27.08 p/Share	48 Added 0.26%	18,080 Dividend Equivalent Unit
Mar 31 2023	BUY Grant, award, or other acquisition	$41,264 $29.08 p/Share	1,419 Added 7.3%	18,032 Common Stock
Feb 17 2023	BUY Grant, award, or other acquisition	$1,251 $35.77 p/Share	35 Added 0.21%	16,613 Dividend Equivalent Unit
Dec 31 2022	BUY Grant, award, or other acquisition	$41,272 $32.86 p/Share	1,256 Added 7.04%	16,578 Common Stock
Nov 10 2022	BUY Grant, award, or other acquisition	$1,161 $38.73 p/Share	30 Added 0.2%	15,322 Dividend Equivalent Unit
Sep 30 2022	BUY Grant, award, or other acquisition	$41,270 $28.19 p/Share	1,464 Added 8.74%	15,292 Common Stock
Aug 11 2022	BUY Grant, award, or other acquisition	$1,011 $36.11 p/Share	28 Added 0.2%	13,828 Dividend Equivalent Unit
Jun 30 2022	BUY Grant, award, or other acquisition	$41,264 $27.62 p/Share	1,494 Added 9.77%	13,800 Common Stock
May 12 2022	BUY Grant, award, or other acquisition	$793 $33.03 p/Share	24 Added 0.19%	12,306 Dividend Equivalent Unit
Mar 31 2022	BUY Grant, award, or other acquisition	$41,285 $34.81 p/Share	1,186 Added 8.81%	12,282 Common Stock
Feb 17 2022	BUY Grant, award, or other acquisition	$742 $43.66 p/Share	17 Added 0.15%	11,096 Dividend Equivalent Unit
Dec 31 2021	BUY Grant, award, or other acquisition	$41,287 $46.39 p/Share	890 Added 7.44%	11,079 Common Stock
Nov 12 2021	BUY Grant, award, or other acquisition	$753 $50.18 p/Share	15 Added 0.15%	10,189 Dividend Equivalent Unit

Also insider at

CVS

CVS HEALTH Corp Healthcare

Director